NVCR News and Press, NovoCure Limited From 12/20/23

2023-12-20 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-28 11:35:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rivian (NASDAQ: RIVN ) stock is a hot topic on Tuesday after Evercore ISI weighed in on the electric vehicle (EV) company’s shares. The big news here is Evercore ISI ...

2023-11-28 11:15:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips FuelCell Energy (NASDAQ: FCEL ) stock is rising higher on Tuesday after the fuel cell energy company announced a collaboration with IBM (NYSE: IBM ). This agreem...

2023-11-28 10:51:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novocure (NASDAQ: NVCR ) layoffs are in the news after the company announced that it will be cutting 13% of its workers in a restructuring effort. Those layoffs will see the...

2023-11-28 07:51:52 ET Novocure ( NASDAQ: NVCR ) announced on Tuesday plans to lay off 13% of its current workforce as part of a strategic restructuring to cut down on expenses. The Root, Switzerland-based oncology company outlined a series of actions to strengthen and optim...

Prioritizing metastatic non-small cell lung cancer launch and focusing research and development activities in areas of greatest anticipated value creation Expected reduction in residual operating expenses of approximately $60 million, including a reduction in headcount of approximately 20...

2023-11-25 16:32:53 ET More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc. Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript Immunocore: First Half Of 2024 IMC-F106...

Novocure (NASDAQ: NVCR) announced today that management will participate in the 35 th Annual Piper Sandler Healthcare Conference on Wednesday, November 29, 2023. William Doyle, Novocure’s Executive Chairman, and Ashley Cordova, Novocure’s Chief Financial Officer, will take part ...

2023-11-16 19:54:20 ET Summary NovoCure is an oncology company that offers a novel therapy for solid tumors called TTFields and comprehensive patient support services. Despite a challenging year, NovoCure's core business is healthy, with high margins and a large patient base. ...

Novocure (NASDAQ: NVCR) today announced that research on Tumor Treating Fields (TTFields) therapy, including new data from the phase 2 2-THE-TOP trial and real-world evidence from patients diagnosed with glioblastoma (GBM) and other central nervous system tumors (CNS), will be presented at the 20...